Amylyx Pharmaceuticals, Inc. Common Stock
Symbol: AMLX (NASDAQ)
13.43
▼ (-9.89%) -1.474
Company Description:
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
Key Stats
- Today's Open: $14.94
- Today's High: $15.13
- Today's Low: $13.426
- Today's Volume: 3.14M
- Yesterday Close: $14.9
- Yesterday High: $14.96
- Yesterday Low: $14.02
- Yesterday Volume: 2.05M
- Last Min Volume: 34
- Last Min High: $13.455
- Last Min Low: $13.426
- Last Min VWAP: $13.45
Company Profile
- Name: Amylyx Pharmaceuticals, Inc. Common Stock
- Website: https://www.amylyx.com
- Listed Date: 2022-01-07
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001658551
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.59B
- Round Lot: 100
- Outstanding Shares: 106.67M
- Asset Type: CS
RECENT FILINGS FOR AMLX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 8-K | View |
| 2025-09-10 | 424B5 | View |
| 2025-09-09 | 424B5 | View |
| 2025-08-27 | 8-K | View |
| 2025-08-14 | 4 | View |
| 2025-08-12 | 144 | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-29 | SCHEDULE 13G | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-06-25 | SCHEDULE 13G | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-05 | 8-K | View |
| 2025-05-27 | 4 | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
Latest News on AMLX